Bioanalytical Development Tools - - BioPharm International


Bioanalytical Development Tools

BioPharm International

19. Procyon Biopharma Inc. Procyon and Medicorp enter into a licensing and distribution agreement for the commercialization of PSP94-based test kits for prostate cancer. 2 March 2005. Montreal, Que. Available at:

20. Garfin D and Ahuja S, eds. Handbook of Isoelectric Focusing and Proteomics, 7. Academic Press. Amsterdam 2005.

21. National Administration for Space and Aeronautics.

22. bioMerieux, Inc. Web site: http://

23. Schmid LS. Economic prosperity drives spectroscopy prospects in 2005. Spectroscopy. 2005 March.

24. Varian, Inc., Varian unveils new magnetic resonance imaging system. Press release. 9 May 2005. Palo Alto CA. Available at:

25. Varian, Inc. Varian, Inc. announces unique probe technology breakthrough for biological solids NMR 6 April 2005. Palo Alto CA. Available at

26. Varian, Inc., Varian, Inc. introduces the world's first salt toleranet cold probe for biological NMR and metabolics studies. 12 April 2005. Palo Alto CA. Available at

27. Tang Y, Chen Y, Lichti CF, Hall RA, Raney KD, Jennings SF. CLPM: A cross-linked peptide mapping algorithm for mass spectrometric analysis. 2 BMC Bioinformatics 2005, 6(Suppl 2):S9. 2005 July.

28. Sweeping changes coming regarding fetal RhD genotyping? Contemporary OB/GYN. 2005 June.

29. Tennant S. Test is found sensitive, specific for Klinefelter's, Urology Times 2005 June.

30. Sinner E. The Simultaneous Monitoring of Surface Plasmon Resonance Spectroscopy (SPS) and Surface Plasmon Resonance Fluorescence Spectroscopy (SPFS). Molecular Recognition Laboratory, Max Planck Institute, Martinsreid Germany. Available at: http://

31. Greenlief M. Lab instructions, CH 4200, University of Missouri, Prof. Greenlief, Fall 2004. Columbia MO. Available at: http://

blog comments powered by Disqus



FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here